Persistence And Adherence With Mirabegron, A New Beta-3 Receptor Agonist, Versus Antimuscarinics In Overactive Bladder- Early Experience In Canada
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.1336
https://www.valueinhealthjournal.com/article/S1098-3015(14)03266-5/fulltext
Title :
Persistence And Adherence With Mirabegron, A New Beta-3 Receptor Agonist, Versus Antimuscarinics In Overactive Bladder- Early Experience In Canada
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03266-5&doi=10.1016/j.jval.2014.08.1336
First page :
A471
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
825